Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Dentistry · Oral Leukoplakia

Which Oral Leukoplakia Features Raise Cancer Risk?

At a Glance

Oral leukoplakia deserves closer evaluation when it is large, uneven in color or texture, red-and-white, raised, ulcerated, found in several areas, or on the tongue or floor of the mouth. These features raise risk but do not diagnose cancer; biopsy and follow-up are essential.

In this answer

6 sections

01

Appearance and Texture

02

Size and Number of Lesions

03

High-Risk Locations

04

Other Risk Factors

05

Changes Over Time and Home Monitoring

06

Combining Clinical Features with Pathology

When evaluating oral leukoplakia—a persistent white patch in the mouth that cannot be explained by another condition—doctors look closely at the lesion’s size, appearance, and location. Certain physical features are associated with a higher likelihood of the patch eventually developing into oral cancer, a process called malignant transformation [1][2].

It is important to understand that these physical features are simply risk associations, not a diagnosis of cancer [3]. No single visual feature can predict exactly what a lesion will do. Instead, these clues help your care team decide how closely to monitor you, whether a biopsy is needed, and which specific areas to test [4]. A biopsy is often recommended—especially for persistent, unexplained, or clinically suspicious lesions—to confirm the diagnosis and check for cellular changes [5].

Appearance and Texture

The way your leukoplakia looks provides important clues for risk assessment. Doctors classify lesions as either homogeneous (a uniform, flat, thin white patch) or nonhomogeneous (irregular in color or texture). Research shows that nonhomogeneous lesions carry a higher average risk of malignant transformation than flat, uniform ones [6][7].

Features that typically prompt closer evaluation include:

  • Erythroleukoplakia: This is a mixed red-and-white patch. While redness can sometimes result from simple inflammation or irritation, persistent red areas can also indicate more significant cellular changes, making this a well-known risk factor that requires careful assessment [8][9].
  • Nodular or Verrucous Texture: Lesions that have raised, bumpy (nodular), or wart-like (verrucous) surfaces are generally watched more closely than flat patches [10].
  • Ulceration and Induration: An open sore (ulcer) within the patch or a hardened, firm area underneath it (induration) are physical changes that warrant prompt evaluation by a specialist [11][12].
Clinical Feature What It May Indicate What It Does NOT Mean
Mixed red and white color Inflammation, trauma, or abnormal cell changes [9] Does not prove the cells are cancerous; a biopsy is needed.
Thick, bumpy, or wart-like surface A nonhomogeneous lesion with a higher statistical risk [10] Does not mean immediate cancer; it guides where the doctor should biopsy.
Ulcer or firm lump (induration) Tissues are breaking down or changing structurally [12] Does not mean untreatable disease; it is a sign to seek prompt medical review.

Size and Number of Lesions

The physical extent of the leukoplakia also plays a role:

  • Larger Size: Studies consistently show an association between larger lesions and a higher likelihood of future transformation [13][2]. While some research notes an increased risk for lesions larger than 200 square millimeters (about a 16-millimeter circle), this is an approximate threshold used in studies, not a definitive rule for every patient [14].
  • Multifocal Lesions: Having leukoplakia in multiple areas of the mouth (multifocality) is generally associated with a higher risk than having a single, isolated patch [15][16]. However, not every patient with multiple patches has a high-risk condition. A specific, rare pattern called proliferative verrucous leukoplakia (PVL) involves widespread, spreading patches that have a very high rate of malignant transformation and require lifelong specialist monitoring [17][18].

High-Risk Locations

Where the leukoplakia is located in your mouth provides additional context for your doctor. Certain areas have thinner tissue or different environments that make them more vulnerable [1].

  • The Tongue: Leukoplakia on the tongue—especially on the sides (lateral) or underneath (ventral)—has historically shown higher rates of transformation in clinical studies [6][16].
  • The Floor of the Mouth: The area under your tongue is also considered a higher-risk zone [16][15].

Lesions on the gums, the hard palate (roof of the mouth), or the inside of the cheeks can still change over time, but generally carry a lower baseline risk than those on the tongue or floor of the mouth [1].

Other Risk Factors

Your clinical risk is not based on physical features alone. Doctors will also consider your lifestyle and health history. Heavy tobacco use, drinking alcohol, or chewing betel/areca nut can significantly amplify the risk of a lesion transforming into cancer [2][19]. Removing sources of physical trauma (like a sharp tooth) and quitting smoking or alcohol can lower your overall risk, though it does not replace the need for regular medical check-ups.

Changes Over Time and Home Monitoring

A leukoplakia patch that changes is a reason for a reassessment. If a previously flat, white patch begins to grow quickly, develop red spots, become bumpy, or forms an ulcer that does not heal within two weeks, it should be examined by your dentist, oral medicine specialist, or ENT doctor promptly [20][12]. Do not wait for your next routine check-up.

When checking your mouth at home, look for these specific physical changes. However, avoid repeatedly rubbing or picking at the lesion, and remember that self-checks do not replace professional examinations.

Combining Clinical Features with Pathology

Doctors do not rely on appearance alone. To get a complete picture of your risk, they combine these visual clues with a biopsy report [21]. The biopsy looks for epithelial dysplasia—abnormal changes in the mouth lining that are associated with an increased future risk of cancer, but are not cancer themselves [22]. Dysplasia is typically graded as mild, moderate, or severe.

Because large or mixed-color lesions can be heterogeneous (varying from one spot to another), a small biopsy might occasionally miss the most abnormal area [23]. If a lesion looks highly suspicious but the biopsy shows only mild dysplasia, your doctor might still recommend surgical removal or targeted repeat biopsies [9].

Living with an uncertain risk can be stressful. Because cancers can occasionally arise from lesions that did not show severe dysplasia initially, an individualized follow-up plan is necessary for almost all oral leukoplakia [5][24]. Your doctor will tailor this plan based on your lesion’s size, appearance, location, and pathology results.

Common questions in this guide

What features make an oral leukoplakia patch more concerning?
Risk is generally higher when a patch is uneven in color or texture, red-and-white, raised or wart-like, ulcerated, firm underneath, large, present in several areas, or located on the tongue or floor of the mouth. These are associations, not proof of cancer. A dentist, oral medicine specialist, or ENT doctor uses them with biopsy results and your health history.
Does a red-and-white leukoplakia patch mean I have cancer?
No. A red-and-white patch can result from irritation or inflammation, but persistent red areas can also be linked with abnormal changes in the mouth lining. Clinical assessment and, when appropriate, a biopsy are needed to determine whether abnormal cell changes or cancer are present.
How do the size and location of leukoplakia affect cancer risk?
Larger lesions and patches in multiple areas are generally associated with greater future risk; studies have used about 200 square millimeters as an approximate threshold, not a rule for every person. Lesions on the sides or underside of the tongue and the floor of the mouth are considered higher-risk locations. A smaller patch in another location can still require biopsy and follow-up.
Can a biopsy miss the highest-risk part of leukoplakia?
Yes. Large or mixed-color patches can contain areas with different levels of abnormality, so a small sample may not represent the most concerning spot. If the lesion looks suspicious but the first result shows only mild changes, the clinician may recommend a targeted repeat biopsy or surgical removal.
When should I have a changing leukoplakia patch checked?
Seek prompt dental or medical review if the patch grows quickly, develops red areas, becomes raised or bumpy, or forms an ulcer that does not heal within two weeks. New pain or a firm area also deserves assessment. Do not wait for a routine appointment when these changes occur.
What is proliferative verrucous leukoplakia, and why is it important?
Proliferative verrucous leukoplakia is a rare pattern in which widespread, spreading, often wart-like patches develop in several areas of the mouth. It has a high risk of malignant transformation and usually requires lifelong specialist monitoring. A clinician must distinguish this pattern from other multifocal leukoplakia.
Can stopping tobacco or alcohol lower oral leukoplakia risk?
Yes. Heavy tobacco use, alcohol use, and chewing betel or areca nut can increase the chance that leukoplakia will transform into cancer, so stopping or reducing these exposures can lower overall risk. Removing ongoing trauma, such as a sharp tooth, may also help, but lifestyle changes do not replace biopsy, follow-up, or specialist care.

Related questions

How Long Is Recovery After Oral Leukoplakia Treatment? How Long Does Oral Leukoplakia Take to Become Oral Cancer? What Should I Eat and How Do I Care for Oral Leukoplakia? Can Alcohol, Tobacco, and Areca Nut Raise Leukoplakia Risk? What Is the Leukoplakia Recurrence Rate After Treatment?
Show more
Is Laser Ablation Better Than Surgery for Oral Leukoplakia? What Happens During and After an Oral Leukoplakia Biopsy? Does Leukoplakia Removal Prevent Future Oral Cancer? Can an Oral Leukoplakia Biopsy Miss Cancer or Dysplasia? What Tests Help Diagnose Oral Leukoplakia Besides Biopsy? Do Multiple Oral Leukoplakia Patches Mean PVL? What to Know What Do Oral Leukoplakia Margins Mean After Excision? When Are Multiple Biopsies Needed for Oral Leukoplakia? Can Leukoplakia Without Dysplasia Become Oral Cancer? Does Dysplasia Grade Affect Oral Leukoplakia Cancer Risk? Is High-Grade Dysplasia or Carcinoma in Situ Cancer? Oral Leukoplakia Pathology: Should I Get a Second Opinion? Should Oral Leukoplakia Without Dysplasia Be Removed? Why Is Tongue or Floor-of-Mouth Leukoplakia High Risk?

Get notified when new evidence is published on oral mucosa leukoplakia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.

    Jäwert F, Pettersson H, Jagefeldt E, et al.

    International journal of oral and maxillofacial surgery 2021; (50(11)):1422-1428 doi:10.1016/j.ijom.2021.01.012.

    PMID: 33674140
  2. 2

    Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis.

    Pimenta-Barros LA, Ramos-García P, González-Moles MÁ, et al.

    Oral diseases 2025; (31(1)):69-80 doi:10.1111/odi.15140.

    PMID: 39314164
  3. 3

    Oral leukoplakia and oral cavity squamous cell carcinoma.

    Bewley AF, Farwell DG

    Clinics in dermatology 2017; (35(5)):461-467 doi:10.1016/j.clindermatol.2017.06.008.

    PMID: 28916027
  4. 4

    Oral potentially malignant disorders: A comprehensive review on clinical aspects and management.

    Warnakulasuriya S

    Oral oncology 2020; (102()):104550 doi:10.1016/j.oraloncology.2019.104550.

    PMID: 31981993
  5. 5

    Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

    Chaturvedi AK, Udaltsova N, Engels EA, et al.

    Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.

    PMID: 31860085
  6. 6

    Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.

    Li J, Liu Y, Zhang H, Hua H

    Oral diseases 2020; (26(7)):1402-1413 doi:10.1111/odi.13372.

    PMID: 32348606
  7. 7

    Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.

    Paglioni MP, Khurram SA, Ruiz BII, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2022; (134(5)):573-587 doi:10.1016/j.oooo.2022.07.006.

    PMID: 36153299
  8. 8

    Malignant Transformation in Leukoplakia and Its Associated Factors in Southern Iran: A Hospital Based Experience.

    Barfi Qasrdashti A, Habashi MS, Arasteh P, et al.

    Iranian journal of public health 2017; (46(8)):1110-1117.

    PMID: 28894713
  9. 9

    Malignant transformation of oral leukoplakia: a follow-up study.

    Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S

    Clinical oral investigations 2020; (24(12)):4563-4569 doi:10.1007/s00784-020-03322-4.

    PMID: 32436158
  10. 10

    Oral leukoplakia in the Sudan: clinicopathological features and risk factors.

    Mustafa MB, Hassan MO, Alhussein A, et al.

    International dental journal 2019; (69(6)):428-435 doi:10.1111/idj.12509.

    PMID: 31407319
  11. 11

    Oral cancer on the gingiva in patients with proliferative leukoplakia: A study of 30 cases.

    Bagan J, Murillo-Cortes J, Leopoldo-Rodado M, et al.

    Journal of periodontology 2019; (90(10)):1142-1148 doi:10.1002/JPER.18-0620.

    PMID: 31074011
  12. 12

    Clinico-Pathological Assessment and Malignant Transformation in Patients with Oral Epithelial Dysplasia - A Follow-up Cohort Study.

    Yasothkumar D, Ramani P, Ramasubramanian A

    Head and neck pathology 2025; (19(1)):96 doi:10.1007/s12105-025-01833-8.

    PMID: 40758174
  13. 13

    Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.

    Yang SW, Lee YS, Chang LC, et al.

    Clinical oral investigations 2021; (25(6)):4045-4058 doi:10.1007/s00784-020-03735-1.

    PMID: 33411001
  14. 14

    Malignant transformation of oral leukoplakia: a systematic review of observational studies.

    Warnakulasuriya S, Ariyawardana A

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2016; (45(3)):155-66 doi:10.1111/jop.12339.

    PMID: 26189354
  15. 15

    Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.

    Yang SW, Lee YC, Lee YS, et al.

    International journal of oral and maxillofacial surgery 2022; (51(11)):1394-1400 doi:10.1016/j.ijom.2022.02.006.

    PMID: 35249786
  16. 16

    Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.

    Guan JY, Luo YH, Lin YY, et al.

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2023; (52(8)):691-700 doi:10.1111/jop.13440.

    PMID: 37224426
  17. 17

    A Scoping Review on Gaps in the Diagnostic Criteria for Proliferative Verrucous Leukoplakia: A Conceptual Proposal and Diagnostic Evidence-Based Criteria.

    González-Moles MÁ, Ramos-García P, Warnakulasuriya S

    Cancers 2021; (13(15)) doi:10.3390/cancers13153669.

    PMID: 34359571
  18. 18

    Malignant Transformation in Oral Potentially Malignant Disorders.

    González-Moles MÁ, Ramos-García P, Warnakulasuriya S

    Oral diseases 2026; doi:10.1111/odi.70527.

    PMID: 42830481
  19. 19

    Oral potentially malignant disorders: risk of progression to malignancy.

    Speight PM, Khurram SA, Kujan O

    Oral surgery, oral medicine, oral pathology and oral radiology 2018; (125(6)):612-627 doi:10.1016/j.oooo.2017.12.011.

    PMID: 29396319
  20. 20

    Changes in the lesion surface suggesting transformation of oral potentially malignant disorders to malignancy - a report of eight cases.

    Kim MJ, Kho HS

    BMC oral health 2023; (23(1)):268 doi:10.1186/s12903-023-02960-w.

    PMID: 37161457
  21. 21

    Multidimensional Artificial Intelligence-Based Cancer Progression Prediction in Oral Leukoplakia.

    Adeoye J, Wang H, Lo AWI, et al.

    Journal of dental research 2026; (105(6)):727-736 doi:10.1177/00220345251378053.

    PMID: 41108137
  22. 22

    Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.

    Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S

    Oral diseases 2021; (27(8)):1881-1895 doi:10.1111/odi.13810.

    PMID: 33606345
  23. 23

    Diagnostic discrepancies in the surgical management of oral epithelial dysplasia - an analysis of concordance between incisional biopsy and definitive resection specimens.

    Maloney B, Jung MS, Byrne J, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2026; (142(3)):362-374 doi:10.1016/j.oooo.2026.03.001.

    PMID: 42020233
  24. 24

    Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia.

    Bukovszky B, Fodor J, Tóth E, et al.

    Journal of clinical medicine 2023; (12(13)) doi:10.3390/jcm12134255.

    PMID: 37445290

This page is for informational purposes only and does not constitute medical advice or diagnose oral cancer. Ask your dentist, oral medicine specialist, or ENT doctor to interpret your lesion and biopsy results.